Caredx Ownership
| CDNA Stock | USD 18.71 0.56 2.91% |
Shares in Circulation | First Issued 2013-03-31 | Previous Quarter 52.9 M | Current Value 58.2 M | Avarage Shares Outstanding 34 M | Quarterly Volatility 18.2 M |
Caredx |
Caredx Stock Ownership Analysis
About 95.0% of the company shares are held by institutions such as insurance companies. The book value of Caredx was currently reported as 6.91. The company had not issued any dividends in recent years. CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. The company was incorporated in 1998 and is headquartered in South San Francisco, California. CareDx operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 633 people. For more info on Caredx Inc please contact Peter Maag at 415 287 2300 or go to https://caredx.com.Caredx Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Caredx is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Caredx Inc backward and forwards among themselves. Caredx's institutional investor refers to the entity that pools money to purchase Caredx's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Bellevue Group Ag | 2024-12-31 | 1.4 M | Jacobs Levy Equity Management, Inc. | 2024-12-31 | 1.2 M | Geode Capital Management, Llc | 2024-12-31 | 1.2 M | D. E. Shaw & Co Lp | 2024-12-31 | 1.1 M | Goldman Sachs Group Inc | 2024-12-31 | 939.5 K | Connor Clark & Lunn Inv Mgmt Ltd | 2024-12-31 | 875.2 K | Dimensional Fund Advisors, Inc. | 2024-12-31 | 743 K | Divisadero Street Capital Management, Lp | 2024-12-31 | 711.8 K | Driehaus Capital Management Llc | 2024-12-31 | 688.4 K | Blackrock Inc | 2024-12-31 | 5.1 M | Vanguard Group Inc | 2024-12-31 | 4.9 M |
Caredx Inc Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Caredx insiders, such as employees or executives, is commonly permitted as long as it does not rely on Caredx's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Caredx insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Caredx Outstanding Bonds
Caredx issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Caredx Inc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Caredx bonds can be classified according to their maturity, which is the date when Caredx Inc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| US14162VAB27 Corp BondUS14162VAB27 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Caredx Corporate Filings
F4 | 12th of March 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
10K | 28th of February 2025 Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance | ViewVerify |
8K | 26th of February 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 14th of February 2025 Other Reports | ViewVerify |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Caredx Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Caredx's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Caredx Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Caredx Inc Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Caredx Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Caredx. If investors know Caredx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Caredx listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.93 | Revenue Per Share | Quarterly Revenue Growth 0.32 | Return On Assets | Return On Equity |
The market value of Caredx Inc is measured differently than its book value, which is the value of Caredx that is recorded on the company's balance sheet. Investors also form their own opinion of Caredx's value that differs from its market value or its book value, called intrinsic value, which is Caredx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Caredx's market value can be influenced by many factors that don't directly affect Caredx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Caredx's value and its price as these two are different measures arrived at by different means. Investors typically determine if Caredx is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Caredx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.